Insider Transactions in Q1 2022 at Hillstream Bio Pharma Inc. (HILS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 14
2022
|
Randy Milby CEO |
BUY
Conversion of derivative security
|
Direct |
921,288
+0.94%
|
$2,763,864
$3.2 P/Share
|
|
Jan 14
2022
|
Leonard L Mazur Director |
BUY
Open market or private purchase
|
Direct |
25,000
+16.81%
|
$100,000
$4.0 P/Share
|
|
Jan 14
2022
|
Leonard L Mazur Director |
BUY
Conversion of derivative security
|
Direct |
98,733
+50.0%
|
$296,199
$3.2 P/Share
|